e-learning
resources
Barcelona 2010
Monday, 20.09.2010
New mechanisms in lung development, acute and chronic lung diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Regulation and overexpression of 85-kDa cytosolic phospholipase A
2
in asthma
M. Sokolowska, J. Stefanska, K. Wodz-Naskiewicz, M. Cieslak, R. Pawliczak (Poland)
Source:
Annual Congress 2010 - New mechanisms in lung development, acute and chronic lung diseases
Session:
New mechanisms in lung development, acute and chronic lung diseases
Session type:
E-Communication Session
Number:
2206
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Sokolowska, J. Stefanska, K. Wodz-Naskiewicz, M. Cieslak, R. Pawliczak (Poland). Regulation and overexpression of 85-kDa cytosolic phospholipase A
2
in asthma. Eur Respir J 2010; 36: Suppl. 54, 2206
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Respiratory sequelae of preterm birth across the life span
Related content which might interest you:
A novel mechanism for upregulation of β
2
-integrin and adhesion of eosinophils by secretory group V phospholipase A
2
independent of cytosolic phospholipase A
2
activation
Source: Annual Congress 2005 - Pulmonary hypertension and fibrosis: novel mechanisms
Year: 2005
Phosphoinositide 3-kinase δ inhibitor suppresses IL-17 expression in a murine model of asthma
Source: Annual Congress 2009 - Animal models of airways inflammation
Year: 2009
Cytosolic phospholipase A2 promoter repeats polymorphisms regulate its transcriptional activity
Source: Eur Respir J 2005; 26: Suppl. 49, 93s
Year: 2005
Novel cytosolic phospholipase A
2
(
cPLA
2
) promoter single nucleotide polymorphisms
Source: Eur Respir J 2006; 28: Suppl. 50, 229s
Year: 2006
Group V phospholipase A
2
(gVPLA
2
) -induced eosinophil synthesis of LTC
4
is independent of mitogen-activated protein kinases (MAPK) activation
Source: Eur Respir J 2001; 18: Suppl. 33, 408s
Year: 2001
The inositol trisphosphate pathway mediates platelet-activating-factor-induced pulmonary oedema
Source: Eur Respir J 2005; 25: 849-857
Year: 2005
Crucial role of phospholipase Cε in the development of asthma in mice
Source: Annual Congress 2011 - Animal models of airway inflammation
Year: 2011
Inhibition of the glycogen synthase kinase 3β reduces steroid function in human monocytes
Source: Annual Congress 2010 - Regulation of airway pharmacology
Year: 2010
Role of protein phosphatase 1 glycogen-associated regulatory subunit in asthma
Source: International Congress 2018 – Identification of therapeutic targets for asthma
Year: 2018
Expression and activation of the major subunit of NF-kB, protein p65, in COPD bronchial glands
Source: Annual Congress 2009 - COPD: basic science and clinical studies
Year: 2009
Increased activity of lipoprotein-associated phospholipase A2 in non-severe asthma
Source: International Congress 2019 – Understanding the mechanisms underlying airway diseases
Year: 2019
Expression of the phosphorylated myristoylated alanine-rich C kinase substrate (MARCKS) in COPD bronchial glands
Source: Annual Congress 2011 - COPD: human studies
Year: 2011
Phosphoinositide 3-kinase ? inhibitor suppresses interleukin-17 expression in a murine asthma model
Source: Eur Respir J 2010; 36: 1448-1459
Year: 2010
Gene transfer of a β-adrenergic receptor kinase inhibitor up-regulated levels of β-adrenergic receptor and cAMP in asthmatic murine lung
Source: Eur Respir J 2005; 26: Suppl. 49, 580s
Year: 2005
Expression of members of the phospholipase A2 family of enzymes in human nasal mucosa
Source: Eur Respir J 2001; 18: 130-138
Year: 2001
Differential actions of phosphatidyinositol 3-kinase inhibitors on respiratory burst and leukotriene C
4
generation in PAF-stimulated human eosinophils
Source: Eur Respir J 2003; 22: Suppl. 45, 547s
Year: 2003
Cytosolic phospholipase A
2
type IVβ induces interleukin – 8 and cyclooxygenase -2 gene expression but does not influence IL-16 and heme oxygenase-1 transcription in human lung cells
Source: Annual Congress 2004 - Inflammation and remodelling in human lungs
Year: 2004
Critical role of cytosolic phospholipase A2? in bronchial mucus hypersecretion in CFTR-deficient mice
Source: Eur Respir J 2010; 36: 1120-1130
Year: 2010
Activation of second messenger pathways in alveolar macrophages by endotoxin
Source: Eur Respir J 2002; 20: 210-222
Year: 2002
Regulation of ENaC activity by alpha1-antitrypsin
Source: Annual Congress 2009 - Novel regulators of alveolar liquid clearance
Year: 2009
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept